$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Androgens in women : Androgen-mediated skin disease and patient evaluation

Journal of the American Academy of Dermatology, v.80 no.6, 2019년, pp.1497 - 1506  

Bienenfeld, Amanda (New York University School of Medicine) ,  Azarchi, Sarah (New York University School of Medicine) ,  Lo Sicco, Kristen (The Ronald O. Perelman Department of Dermatology, New York University School of Medicine) ,  Marchbein, Shari (The Ronald O. Perelman Department of Dermatology, New York University School of Medicine) ,  Shapiro, Jerry (The Ronald O. Perelman Department of Dermatology, New York University School of Medicine) ,  Nagler, Arielle R. (The Ronald O. Perelman Department of Dermatology, New York University School of Medicine)

Abstract AI-Helper 아이콘AI-Helper

Androgens are produced throughout the body in steroid-producing organs, such as the adrenal glands and ovaries, and in other tissues, like the skin. Several androgens are found normally in women, including dehydroepiandrosterone, dehydroepiandrosterone-sulfate, testosterone, dihydrotestosterone, and...

Keyword

참고문헌 (79)

  1. J Steroid Biochem Mol Biol Slominski 137 107 2013 10.1016/j.jsbmb.2013.02.006 Steroidogenesis in the skin: implications for local immune functions 

  2. J Invest Dermatol Thiboutot 120 905 2003 10.1046/j.1523-1747.2003.12244.x Human skin is a steroidogenic tissue: steroidogenic enzymes and cofactors are expressed in epidermis, normal sebocytes, and an immortalized sebocyte cell line (SEB-1) 

  3. Best Pract Res Clin Obstet Gynaecol Lizneva 37 98 2016 10.1016/j.bpobgyn.2016.05.003 Androgen excess: investigations and management 

  4. J Am Acad Dermatol Sperling 28 669 1993 10.1016/0190-9622(93)70092-8 Androgen biology as a basis for the diagnosis and treatment of androgenic disorders in women. I 

  5. Clin Dermatol Essah 24 289 2006 10.1016/j.clindermatol.2006.04.004 Dermatology of androgen-related disorders 

  6. Steroids Slominski 103 72 2015 10.1016/j.steroids.2015.04.006 On the role of skin in the regulation of local and systemic steroidogenic activities 

  7. Clin Endocrinol Metab Longcope 15 213 1986 10.1016/S0300-595X(86)80021-4 Adrenal and gonadal androgen secretion in normal females 

  8. J Am Acad Dermatol Lookingbill 12 481 1985 10.1016/S0190-9622(85)70067-9 Tissue production of androgens in women with acne 

  9. Horm Metab Res Zouboulis 39 85 2007 10.1055/s-2007-961807 Sexual hormones in human skin 

  10. Dermatology Zouboulis 196 21 1998 10.1159/000017861 The human sebocyte culture model provides new insights into development and management of seborrhoea and acne 

  11. Endocr Rev Slominski 34 827 2013 10.1210/er.2012-1092 Key role of CRF in the skin stress response system 

  12. Fertil Steril Burger 77 suppl 4 S3 2002 10.1016/S0015-0282(02)02985-0 Androgen production in women 

  13. Metabolism Vierhapper 52 927 2003 10.1016/S0026-0495(03)00060-X Production rates of testosterone and of dihydrotestosterone in female pattern hair loss 

  14. J Endocrinol Choudhry 133 467 1992 10.1677/joe.0.1330467 Localization of androgen receptors in human skin by immunohistochemistry: implications for the hormonal regulation of hair growth, sebaceous glands and sweat glands 

  15. J Invest Dermatol Liang 100 663 1993 10.1111/1523-1747.ep12472330 Immunocytochemical localization of androgen receptors in human skin using monoclonal antibodies against the androgen receptor 

  16. J Dtsch Dermatol Ges Degitz 5 316 2007 10.1111/j.1610-0387.2007.06274.x Pathophysiology of acne 

  17. Endocr Rev Deplewski 21 363 2000 10.1210/edrv.21.4.0404 Role of hormones in pilosebaceous unit development 

  18. Arch Dermatol Res Lai 304 499 2012 10.1007/s00403-012-1265-x The role of androgen and androgen receptor in skin-related disorders 

  19. Br J Dermatol Bhate 168 474 2013 10.1111/bjd.12149 Epidemiology of acne vulgaris 

  20. Skin Pharmacol Physiol Holzmann 27 suppl 1 3 2014 10.1159/000354887 Postadolescent acne in females 

  21. J Am Acad Dermatol Goulden 41 577 1999 Prevalence of facial acne in adults 

  22. Br J Dermatol Ramos-e-Silva 172 suppl 1 20 2015 10.1111/bjd.13638 Acne in women 

  23. J Am Acad Dermatol Housman 71 847.e1 2014 10.1016/j.jaad.2014.05.007 Polycystic ovary syndrome: a review for dermatologists: part I. Diagnosis and manifestations 

  24. J Am Acad Dermatol Schmidt 73 672 2015 10.1016/j.jaad.2015.05.026 Evidence-based approach to cutaneous hyperandrogenism in women 

  25. Br J Dermatol Bettoli 172 suppl 1 37 2015 10.1111/bjd.13681 Is hormonal treatment still an option in acne today? 

  26. J Clin Endocrinol Metab Imperato-McGinley 76 524 1993 The androgen control of sebum production. Studies of subjects with dihydrotestosterone deficiency and complete androgen insensitivity 

  27. Med Clin North Am Lolis 93 1161 2009 10.1016/j.mcna.2009.08.008 Acne and systemic disease 

  28. J Invest Dermatol Thiboutot 105 209 1995 10.1111/1523-1747.ep12317162 Activity of the type 1 5 alpha-reductase exhibits regional differences in isolated sebaceous glands and whole skin 

  29. Med Electron Microsc Toyoda 34 29 2001 10.1007/s007950100002 Pathogenesis of acne 

  30. Best Pract Res Clin Endocrinol Metab Yildiz 20 167 2006 10.1016/j.beem.2006.02.004 Diagnosis of hyperandrogenism: clinical criteria 

  31. J Invest Dermatol Thiboutot 123 1 2004 10.1111/j.1523-1747.2004.t01-2-.x Regulation of human sebaceous glands 

  32. J Invest Dermatol Fluhr 117 44 2001 10.1046/j.0022-202x.2001.01399.x Generation of free fatty acids from phospholipids regulates stratum corneum acidification and integrity 

  33. J Invest Dermatol Elias 125 183 2005 10.1111/j.0022-202X.2005.23668.x Stratum corneum defensive functions: an integrated view 

  34. Fertil Steril Slayden 75 889 2001 10.1016/S0015-0282(01)01701-0 Hyperandrogenemia in patients presenting with acne 

  35. Arch Dermatol Reingold 123 209 1987 10.1001/archderm.1987.01660260079018 The relationship of mild hirsutism or acne in women to androgens 

  36. Dermatology da Cunha 226 167 2013 10.1159/000347196 Androgenic hormone profile of adult women with acne 

  37. JAMA Dermatol Schmidt 152 391 2016 10.1001/jamadermatol.2015.4498 Cutaneous findings and systemic associations in women with polycystic ovary syndrome 

  38. Clin Dermatol Barros 35 168 2017 10.1016/j.clindermatol.2016.10.009 Hormonal therapies for acne 

  39. Clin Dermatol Katsambas 28 17 2010 10.1016/j.clindermatol.2009.03.006 Hormonal therapy for acne: why not as first line therapy? Facts and controversies 

  40. Obstet Gynecol Azziz 101 995 2003 The evaluation and management of hirsutism 

  41. Dermatol Ther Somani 21 376 2008 10.1111/j.1529-8019.2008.00219.x The clinical evaluation of hirsutism 

  42. J Clin Endocrinol Metab Ferriman 21 1440 1961 10.1210/jcem-21-11-1440 Clinical assessment of body hair growth in women 

  43. Endocr Pract Goodman 7 120 2001 10.4158/EP.7.2.120 American Association of Clinical Endocrinologists medical guidelines for the clinical practice for the diagnosis and treatment of hyperandrogenic disorders 

  44. Dermatol Ther Randall 21 314 2008 10.1111/j.1529-8019.2008.00214.x Androgens and hair growth 

  45. J Clin Endocrinol Metab Martin 103 1233 2018 10.1210/jc.2018-00241 Evaluation and treatment of hirsutism in premenopausal women: an Endocrine Society clinical practice guideline 

  46. Am J Obstet Gynecol Souter 191 1914 2004 10.1016/j.ajog.2004.06.064 The prevalence of androgen excess among patients with minimal unwanted hair growth 

  47. Hum Reprod Update Escobar-Morreale 18 146 2012 10.1093/humupd/dmr042 Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society 

  48. N Engl J Med Rosenfield 353 2578 2005 10.1056/NEJMcp033496 Clinical practice. Hirsutism 

  49. J Clin Endocrinol Metab Azziz 89 453 2004 10.1210/jc.2003-031122 Androgen excess in women: experience with over 1000 consecutive patients 

  50. Dermatoendocrinol Chen 1 81 2009 10.4161/derm.1.2.8354 Hormones and the pilosebaceous unit 

  51. N Engl J Med Shapiro 357 1620 2007 10.1056/NEJMcp072110 Clinical practice. Hair loss in women 

  52. Br J Dermatol Birch 154 85 2006 10.1111/j.1365-2133.2005.06953.x Female pattern hair loss, sebum excretion and the end-organ response to androgens 

  53. J Am Acad Dermatol Futterweit 19 831 1988 10.1016/S0190-9622(88)70241-8 The prevalence of hyperandrogenism in 109 consecutive female patients with diffuse alopecia 

  54. Br J Dermatol Mirmirani 165 suppl 3 7 2011 10.1111/j.1365-2133.2011.10629.x Hormonal changes in menopause: do they contribute to a ‘midlife hair crisis’ in women? 

  55. Exp Dermatol Zouboulis 13 suppl 4 5 2004 10.1111/j.1600-0625.2004.00255.x Androgen action on human skin - from basic research to clinical significance 

  56. J Invest Dermatol Millar 118 216 2002 10.1046/j.0022-202x.2001.01670.x Molecular mechanisms regulating hair follicle development 

  57. J Invest Dermatol Shimizu 122 239 2004 10.1046/j.0022-202X.2004.22224.x Wnt signaling through the beta-catenin pathway is sufficient to maintain, but not restore, anagen-phase characteristics of dermal papilla cells 

  58. Br J Dermatol Leiros 166 1035 2012 10.1111/j.1365-2133.2012.10856.x Hair follicle stem cell differentiation is inhibited through cross-talk between Wnt/beta-catenin and androgen signalling in dermal papilla cells from patients with androgenetic alopecia 

  59. Br J Dermatol Ali 164 508 2011 Physiological changes in scalp, facial and body hair after the menopause: a cross-sectional population-based study of subjective changes 

  60. Clin Endocrinol (Oxf) Rothman 75 160 2011 10.1111/j.1365-2265.2011.04040.x How should postmenopausal androgen excess be evaluated? 

  61. Br J Dermatol Birch 144 297 2001 10.1046/j.1365-2133.2001.04018.x Hair density, hair diameter and the prevalence of female pattern hair loss 

  62. Eur J Endocrinol Markopoulos 172 R79 2015 10.1530/EJE-14-0468 Hyperandrogenism after menopause 

  63. Eur J Endocrinol Sarfati 165 779 2011 10.1530/EJE-11-0542 Impact of clinical, hormonal, radiological, and immunohistochemical studies on the diagnosis of postmenopausal hyperandrogenism 

  64. Fertil Steril Fauser 97 28 2012 10.1016/j.fertnstert.2011.09.024 Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group 

  65. Eur J Obstet Gynecol Reprod Biol Uysal 211 21 2017 10.1016/j.ejogrb.2017.01.054 Is acne a sign of androgen excess disorder or not? 

  66. Endocr Pract Goodman 21 1291 2015 10.4158/EP15748.DSC American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: guide to the best practices in the evaluation and treatment of polycystic ovarian syndrome-part 1 

  67. J Am Acad Dermatol Zaenglein 74 945 2016 10.1016/j.jaad.2015.12.037 Guidelines of care for the management of acne vulgaris 

  68. J Am Acad Dermatol Sperling 28 901 1993 10.1016/0190-9622(93)70129-H Androgen biology as a basis for the diagnosis and treatment of androgenic disorders in women. II 

  69. J Am Acad Dermatol Gollnick 49 S1 2003 10.1067/mjd.2003.618 Management of acne: a report from a Global Alliance to Improve Outcomes in Acne 

  70. Medicine (Baltimore) Karrer-Voegeli 88 32 2009 10.1097/md.0b013e3181946a2c Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism 

  71. Skinmed Clark 12 84 2014 Dermatologic manifestation of hyperandrogenism: a retrospective chart review 

  72. Endocr Rev Azziz 21 347 2000 Idiopathic hirsutism 

  73. J Clin Endocrinol Metab Rosner 92 405 2007 10.1210/jc.2006-1864 Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement 

  74. Arch Gynecol Obstet Hassa 274 227 2006 10.1007/s00404-006-0173-8 Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam’s criteria and women whose only clinical signs are oligo/anovulation or hirsutism 

  75. Hum Reprod 19 41 2004 10.1093/humrep/deh098 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) 

  76. Reed 2000 Endotext The normal menstrual cycle and the control of ovulation 

  77. J Clin Endocrinol Metab Carmina 91 2 2006 10.1210/jc.2005-1457 Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism 

  78. Fertil Steril Glintborg 82 1570 2004 10.1016/j.fertnstert.2004.06.040 Prevalence of endocrine diseases and abnormal glucose tolerance tests in 340 Caucasian premenopausal women with hirsutism as the referral diagnosis 

  79. Fertil Steril 86 5 suppl 1 S241 2006 The evaluation and treatment of androgen excess 

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로